elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q29622818-D97D9145-2BBC-41C2-94A5-145AFE6416CE
Q29622818-D97D9145-2BBC-41C2-94A5-145AFE6416CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q29622818-D97D9145-2BBC-41C2-94A5-145AFE6416CE
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
P407
Q29622818-D97D9145-2BBC-41C2-94A5-145AFE6416CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q29622818-D97D9145-2BBC-41C2-94A5-145AFE6416CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
704556fc27c83eca9a27cda17896d69651633f9c
P407
English